The real-world efficacy and safety of frontline therapy of obinutuzumab plus bendamustine for untreated high-tumor-burden follicular lymphoma

• DOI: 10.1007/s10147-025-02691-8
• Publication Date: 2025-01-07T09:53:24Z
• Authors: Hiroaki Nagata; Taku Tsukamoto; Tsutomu Kobayashi; Ryoichi Takahashi; Akira Okano; Hitoji Uchiyama; Eri Kawata; Nobuhiko Uoshima; Hiroto Kaneko; Shin-ichi Fuchida; Daichi Nishiyama; Mitsushige Nakao; Takahiro Fujino; Shinsuke Mizutani; Yuji Shimura; Junya Kuroda
• Keywords: Bendamustine; Follicular lymphoma; Obinutuzumab; Leukocytopenia